Left untreated, Helicobacter pylori triggers a slow chain of damage that begins with chronic stomach inflammation and, over years or decades, can progress through ulcers, precancerous tissue changes, and in a small but meaningful fraction of carriers, gastric cancer or lymphoma. Most infected people never develop cancer, but virtually all develop some degree of chronic gastritis, and the bacterium’s effects reach beyond the stomach into blood counts, nutrient absorption, and appetite-regulating hormones. The longer the infection persists, the harder it becomes to fully reverse the damage it has caused.
Chronic Gastritis Is the Universal Starting Point
Nearly everyone carrying H. pylori develops chronic active gastritis, an ongoing inflammatory reaction in the stomach lining. The immune system recognizes the bacterium and sends waves of inflammatory cells into the gastric tissue, but it never manages to eliminate the infection. The resulting standoff produces a characteristic mix of immune cells dominated by a pro-inflammatory response.1FEMS Immunology & Medical Microbiology. The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori This low-grade battle in the stomach wall can persist for decades without producing obvious symptoms. Many people feel nothing at all, which is one reason the infection so often goes untreated.
H. pylori is remarkably well adapted to life in the stomach. It produces an enzyme called urease that neutralizes the acid in its immediate environment, and the activity of this system ramps up as stomach acid increases, giving the bacterium a built-in survival mechanism.2GASTROENTEROLOGY. Regulation of Urease Activity in Helicobacter pylori and Its Role in Acid Adaptation and Gastric Colonization The bacterium also shifts its surface proteins rapidly enough to stay a step ahead of the immune response, which is why the inflammation persists without resolution. Your immune system keeps fighting, but it keeps losing.
From Inflammation to Ulcers
For a subset of infected people, the chronic inflammation weakens the stomach’s protective mucus layer enough that acid begins to erode the tissue beneath it, forming peptic ulcers. These can appear in the stomach itself or in the upper part of the small intestine (the duodenum). Symptoms range from a gnawing or burning abdominal pain to nausea, vomiting, and unintended weight loss. In more serious cases, ulcers bleed or perforate the stomach wall entirely, which is a medical emergency.3PubMed Central. Peptic Ulcer Disease and Helicobacter pylori infection
Before the discovery of H. pylori in the 1980s, ulcers were blamed on stress and spicy food, and patients were told to change their diets. The realization that a treatable bacterial infection was responsible for most ulcers was one of the biggest shifts in modern gastroenterology. Without treatment, ulcers tend to recur. Even when they heal temporarily with acid-reducing medication, the underlying infection keeps creating the conditions for new ulcers to form.
The Precancerous Cascade
The most concerning long-term consequence of untreated H. pylori is a stepwise transformation of the stomach lining that can eventually lead to cancer. Researchers call this the Correa cascade, after the pathologist who first described it. The sequence starts with the chronic gastritis that all infected people develop. In some, the inflammation gradually destroys the stomach’s acid-producing glands, a condition called atrophic gastritis. The lost glandular tissue gets replaced by cells that normally belong in the intestines, a change known as intestinal metaplasia. From there, the cells can become increasingly abnormal, progressing through dysplasia and potentially to gastric adenocarcinoma.4PubMed Central. The gastric precancerous cascade
A large Korean study covering nearly seven million people quantified the risk at each stage. H. pylori infection raised the overall risk of gastric cancer roughly sixfold compared to uninfected people. The infection also increased the risk of the intermediate stages: atrophic gastritis and intestinal metaplasia were about 40% more common in infected individuals, and gastric adenomas (a type of precancerous growth) were almost six times more common.5PubMed Central. Quantifying the effects of the Correa pathway from Helicobacter pylori infection to gastric cancer: causal inference found in 6.8 million Koreans That sixfold figure sounds alarming, but because the baseline rate of gastric cancer is low in most Western populations, the absolute risk for any individual carrier remains small. Still, across the roughly half of the world’s population carrying H. pylori, even a small percentage translates to hundreds of thousands of cancer cases globally each year.
Not all H. pylori strains carry equal risk. Two bacterial proteins, CagA and VacA, are particularly associated with more aggressive disease. CagA gets injected directly into stomach cells and interferes with signaling pathways that control cell growth and survival. VacA promotes the accumulation of CagA inside those cells, amplifying the effect.6Scientific Reports. VacA promotes CagA accumulation in gastric epithelial cells during Helicobacter pylori infection Both toxins can activate pathways linked to cancer development, and strains carrying both are associated with worse outcomes than strains lacking them.7Frontiers in Microbiology. A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease
MALT Lymphoma
Gastric cancer is not the only malignancy linked to untreated H. pylori. The bacterium is also the primary driver of a rare type of stomach lymphoma called MALT lymphoma (mucosa-associated lymphoid tissue lymphoma). The stomach normally has very little lymphoid tissue, but the chronic immune stimulation from H. pylori causes lymphoid tissue to accumulate. Over time, the ongoing stimulation can push B cells (a type of immune cell) toward uncontrolled growth.8PubMed Central. Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas
The CagA protein plays a role here too. When it enters B cells, it interferes with the normal signals that would trigger cell death, effectively keeping pre-cancerous cells alive longer than they should be.9PubMed. Helicobacter pylori and mucosa-associated lymphoid tissue: what’s new The good news is that early-stage MALT lymphoma is one of the few cancers that can sometimes be cured simply by eliminating the infection. Once H. pylori is eradicated with antibiotics, the lymphoma regresses in a substantial number of cases. But if the lymphoma acquires certain genetic changes that make it independent of bacterial stimulation, eradication alone may no longer be enough. The window for this simpler treatment narrows the longer the infection goes unaddressed.
Effects Beyond the Stomach
H. pylori’s consequences are not confined to the stomach lining. One of the better-documented extra-gastric effects involves blood platelets. A condition called immune thrombocytopenia, where the body’s immune system destroys its own platelets and impairs blood clotting, has been linked to H. pylori infection. In a meaningful proportion of patients with this condition, eradicating the bacterium leads to a recovery in platelet counts without any other treatment.10PubMed Central. Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms
The chronic inflammation in the stomach also interferes with nutrient absorption. Atrophic gastritis destroys the cells that produce stomach acid and intrinsic factor, both of which are needed to absorb iron and vitamin B12 properly. Long-standing untreated infection can therefore contribute to iron-deficiency anemia and B12 deficiency, particularly in populations where dietary intake of these nutrients is already borderline.
There are also metabolic ripple effects. H. pylori colonization alters levels of ghrelin and leptin, hormones that regulate hunger, satiety, and energy balance. In a study of schoolchildren, those infected with H. pylori had lower levels of both leptin and obestatin compared to uninfected children, even after accounting for body size.11Pediatric Research. Helicobacter pylori infection and serum leptin, obestatin, and ghrelin levels in Mexican schoolchildren Research in adults has confirmed that eradicating the infection changes circulating ghrelin and leptin levels and is associated with shifts in body weight.12PubMed Central. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin The clinical significance of these hormonal changes is still being worked out, but they suggest the infection’s influence extends into appetite regulation and metabolism in ways that are easy to overlook.
What the Infection Does to the Stomach’s Microbiome
Your stomach is not sterile. It harbors a community of microbes, and H. pylori reshapes that community dramatically. When present, the bacterium dominates the gastric microbiome and reduces the diversity of other species living there.13PubMed Central. Interactions between H. pylori and the Gastric Microbiome: Impact on Gastric Homeostasis and Disease More virulent strains carrying CagA appear to cause more severe reductions in microbial diversity and alter the relationships between the remaining bacterial species.14Frontiers in Cellular and Infection Microbiology. Helicobacter pylori infection altered gastric microbiota in patients with chronic gastritis
The consequences of this microbial takeover are not entirely clear yet, but the disruption extends beyond the stomach. H. pylori colonization has been correlated with changes in the microbial communities of the colon as well.15PubMed Central. The interplay between Helicobacter pylori and gastrointestinal microbiota Since the gut microbiome is increasingly recognized as important for immune regulation, nutrient processing, and even mental health, this downstream disturbance could have implications that researchers are only beginning to trace.
Different Trajectories in Children and Adults
Most H. pylori infections are acquired during childhood, usually through close contact within families.16PubMed Central. Helicobacter pylori, transmission routes and recurrence of infection: state of the art But the infection behaves differently in children than in adults. Children tend to mount a more tolerant immune response to the bacterium, producing anti-inflammatory signals that keep the reaction muted. This means infected children often have minimal stomach inflammation and rarely develop ulcers. Adults, by contrast, mount a more aggressive inflammatory response that drives tissue damage.17PubMed Central. Helicobacter pylori Immune Response in Children Versus Adults
This difference in immune response explains why the serious consequences of H. pylori, including ulcers, gastric cancer, and MALT lymphoma, are overwhelmingly adult diseases even though the infection was picked up decades earlier. The shift from tolerance to inflammation appears to happen gradually as the immune system matures and the infection accumulates years of low-level damage. A child who is asymptomatic today could be developing the early stages of atrophic gastritis by middle age if the infection is never treated.
Does the Infection Ever Clear on Its Own?
One common question is whether you can simply wait it out. The short answer is that spontaneous clearance does happen, but it is uncommon enough that you should not count on it. An Italian study found that H. pylori infection was more dynamic than previously appreciated, with some people losing and regaining the infection over time. Spontaneous clearance was more common in younger people, males, and those living in less crowded households.18PubMed. High exposure, spontaneous clearance, and low incidence of active Helicobacter pylori infection: the Sorbo San Basile study An older study documented twelve patients whose biopsies became H. pylori-negative without targeted antibiotics, though most of them were taking omeprazole (a proton pump inhibitor) for other reasons, and two later tested positive again.19PubMed. Disappearance of Helicobacter without antibiotics in 12 patients with gastritis
The overall picture is that while the bacterium may come and go more than early research suggested, lasting spontaneous eradication is rare. Without targeted antibiotic therapy, the reinfection rate remains low after successful treatment, but the infection itself almost never resolves permanently on its own.16PubMed Central. Helicobacter pylori, transmission routes and recurrence of infection: state of the art Waiting simply gives the precancerous cascade more time to advance.
The Point of No Return
Eradicating H. pylori reverses some of the damage it has caused, but not all of it. Researchers describe a “point of no return” in the precancerous cascade: once intestinal metaplasia becomes extensive and DNA changes in the stomach lining accumulate beyond a certain threshold, killing the bacterium may no longer be enough to prevent cancer from eventually developing.20PubMed Central. Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan The exact location of this threshold has not been pinpointed, but the consensus is that eradication should happen before severe atrophy of the stomach lining has set in.21PubMed Central. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions
This has a practical implication that is easy to miss. Even after successful eradication, people who already had significant atrophic gastritis or intestinal metaplasia at the time of treatment may still need ongoing cancer surveillance. Eliminating the bacterium lowers the risk but does not reset it to zero if the tissue changes have already gone far enough. The people who benefit most from eradication are those treated relatively early, before the cascade has advanced substantially.
Antibiotic Resistance Complicates Treatment
For people who do seek treatment, a growing challenge is antibiotic resistance. H. pylori eradication typically requires a combination of two antibiotics plus an acid-suppressing drug, but resistance to key antibiotics has been rising worldwide. In one study comparing newly diagnosed patients to those who had already failed a round of treatment, resistance to clarithromycin (a first-line antibiotic) was found in about 11% of new cases but jumped to 39% in the treatment-resistant group. Metronidazole resistance was even more common, present in 38% of new patients and 70% of those who had failed prior therapy.22PLOS ONE. Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure
These numbers mean that a person who delays treatment and then needs it later may face a harder fight. Prior exposure to antibiotics for unrelated infections can also breed resistance in H. pylori living quietly in the stomach. The bacterium’s resistance patterns vary by region, which is why guidelines increasingly recommend susceptibility testing or local resistance data to guide the choice of antibiotics rather than relying on a one-size-fits-all regimen.
How Testing Works
If you are wondering whether you carry H. pylori, several non-invasive tests exist. The urea breath test is considered the most accurate non-invasive option. You swallow a small amount of labeled urea, and if H. pylori is present in your stomach, its urease enzyme breaks it down and produces labeled carbon dioxide that can be measured in your breath.23PubMed Central. Non-invasive diagnostic tests for Helicobacter pylori infection Stool antigen tests are a less expensive alternative with similar accuracy and are useful both for initial diagnosis and for confirming eradication after treatment. Blood antibody tests are the least reliable for active infection because antibodies can linger for months or years after the bacterium has been cleared, making it impossible to distinguish a current infection from a past one.24PubMed Central. Non-invasive tests for the diagnosis of helicobacter pylori: state of the art
The Paradox of Potential Protective Effects
H. pylori has colonized humans for at least 5,300 years, as confirmed by genomic analysis of the bacterium found in the stomach of Ötzi the Iceman, the famous mummy preserved in the Alps.25PubMed Central. The 5300-year-old Helicobacter pylori genome of the Iceman The organism has co-evolved with us for so long that its disappearance from modern populations has coincided with, and may have contributed to, rising rates of certain other diseases.
The most studied protective association involves esophageal adenocarcinoma. H. pylori, particularly strains that cause atrophic gastritis and reduce stomach acid production, appears to lower the risk of this type of esophageal cancer. The proposed mechanisms include reduced acid reflux into the esophagus and alterations in ghrelin levels that affect lower esophageal function.26PubMed Central. Is Helicobacter pylori infection protective against esophageal cancer?
There is also a negative association between H. pylori infection and allergic diseases, including asthma. As H. pylori prevalence has fallen in developed countries, rates of allergic conditions have climbed.27PubMed Central. Update on the association between Helicobacter pylori infection and asthma in terms of microbiota and immunity A Greek case-control study found that asthmatic children were significantly less likely to be infected with H. pylori than non-asthmatic children.28PubMed Central. Inverse association between Helicobacter pylori infection and childhood asthma in Greece: a case-control study These findings do not prove that H. pylori prevents asthma, and no one is recommending deliberate infection. But they do complicate the narrative. The bacterium is not purely a pathogen in every context, and its long co-evolutionary history with humans means its removal may carry trade-offs that are still being mapped. For now, the weight of evidence still favors treating known infections, particularly in adults with symptoms or risk factors for gastric cancer, but the research into protective effects is a reminder that the biology is more tangled than a simple villain story.